UBS AM’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $13M | Hold |
|
|||||
|
2023
Q1 | $13M | Sell |
|
|||||
|
2022
Q4 | $14.1M | Sell |
|
|||||
|
2022
Q3 | $15.9M | Sell |
|
|||||
|
2022
Q2 | $12.6M | Sell |
|
|||||
|
2022
Q1 | $16.7M | Buy |
|
|||||
|
2021
Q4 | $18.8M | Buy |
|
|||||
|
2021
Q3 | $46.4M | Buy |
|
|||||
|
2021
Q2 | $36.9M | Buy |
|
|||||
|
2021
Q1 | $27.9M | Buy |
|
|||||
|
2020
Q4 | $36.9M | Sell |
|
|||||
|
2020
Q3 | $21.9M | Buy |
|